Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.

A4M Medicine Redefined

Non-Profit Trusted Source of Non-Commercial Health Information

Cognitive Decline a...
 
Notifications
Clear all

Cognitive Decline and Antihypertensive Use: New Data

1 Posts
1 Users
0 Reactions
113 Views
Posts: 1
Guest
Topic starter
(@Dr. Know)
New Member
Joined: 4 months ago
  • Deprescribing antihypertensives was associated with a 12% lower likelihood of progressing to a worse CFS per 12-week period (odds ratio [OR], 0.88; 95% CI, 0.78-0.99) compared with stable users.
  • Among residents with dementia, deprescribing was associated with a 16% reduced likelihood of cognitive decline per 12-week period (OR, 0.84; 95% CI, 0.72-0.98).
  • At the end of follow-up, 12% of residents had a higher CFS score and 7.7% had a lower CFS score.
  • In the intention-to-treat analysis, the association between deprescribing antihypertensive medications and reduced cognitive decline remained consistent (OR, 0.94; 95% CI, 0.90-0.98).

https://www.medscape.com/viewarticle/cognitive-decline-and-antihypertensive-use-new-data-2024a1000isw?st=fpf&scode=msp&socialSite=facebook&form=fpf&icd=login_success_fb_match_fpf

Leave a reply

Author Name

Author Email

Title *

My Media   or drag and drop it here. Max file size 50MB
 
Preview 0 Revisions Saved